Category: Hansen Medical Inc.Syndicate content

Hansen Medical taps ex-Teleflex prez Vance as new CEO

May 6, 2014 by Brad Perriello

Hansen Medical names ex-Teleflex president Cary Vance as its new president & CEO, replacing Bruce Barclay, who was oustered in February.

Hansen Medical taps ex-Teleflex exec Vance as new CEO

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Morgan Stanley: Medtech underperformed in April

May 5, 2014 by Brad Perriello

Medtech stocks flipped the script last month, having underperformed the S&P 500 by 4% after out-performing the index by nearly 5% during the 1st quarter, according to a Morgan Stanley analysis.

Morgan Stanley: Medtech underperformed in April

The medical device sector under-performed the S&P 500 index in April after a sharp swing over-performance during the 1st quarter, according to analysts at Morgan Stanley.

The 30 medtech stocks Morgan Stanley covers collectively under-performed the S&P by 4.1%, after besting the index by 4.9% during the 1st quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Personnel Moves: IOM prez steps down from MDT board

March 5, 2014 by MassDevice staff

Here's a look at some of the top personnel stories for medical device companies this week.

New IOM president leaving Medtronic's board

February 21, 2014 by Arezu Sarvestani

Hansen Medical CEO Barclay is out after Q4 slip to red

February 21, 2014 by Brad Perriello

Hansen Medical lets CEO Bruce Barclay go after the surgical robot maker reports a slide to losses during the 4th quarter.

Hansen Medical CEO Barclay is out after Q4 slip to red

Hansen Medical (NSDQ:HNSN) is looking for a new CEO to replace Bruce Barclay, who was let go after the robotic surgery company reported a slide to red ink for the 4th quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hansen Medical soars on FDA win for smaller robotic catheter

February 11, 2014 by Arezu Sarvestani

Hansen Medical's stock rises 20% on FDA clearance for its smaller-diameter Magellan 6Fr catheter and the mandatory exercise of $14 million in Series A warrants.

Hansen Medical lands FDA win for smaller robotic catheter

California surgical robotics maker Hansen Medical (NSDQ:HNSN) won FDA clearance for a smaller version of its Magellan catheter for use in peripheral vascular interventions.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp